- Report
- February 2024
Japan
From €3185EUR$3,500USD£2,731GBP
- Report
- February 2024
Italy
From €3185EUR$3,500USD£2,731GBP
- Report
- February 2024
Serbia
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Russia
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Romania
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Qatar
From €2594EUR$2,850USD£2,224GBP
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Portugal
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Poland
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Philippines
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Peru
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Turkey
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Thailand
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Taiwan
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Switzerland
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Sweden
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
South Korea
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
South Africa
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Slovenia
From €2594EUR$2,850USD£2,224GBP
- Report
- February 2024
Slovakia
From €2594EUR$2,850USD£2,224GBP

The Immunoglobulin A (IgA) Test is a type of In Vitro Diagnostics (IVD) used to detect the presence of IgA antibodies in a patient's blood. IgA is an antibody produced by the body to fight off infections and is found in the mucous membranes of the respiratory and gastrointestinal tracts. The IgA Test is used to diagnose a variety of conditions, including allergies, autoimmune diseases, and infections. It is also used to monitor the effectiveness of treatments for these conditions.
The IgA Test market is a subset of the larger IVD market, which is estimated to be worth billions of dollars. The IgA Test market is expected to grow in the coming years due to the increasing prevalence of allergies, autoimmune diseases, and infections.
Some companies in the IgA Test market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more